Home
>
National Drug Code (NDC)
>
PRINIVIL
PRINIVIL - 0006-0019-54 - (lisinopril)
Drug Information of PRINIVIL
| Product NDC: | 0006-0019 |
| Proprietary Name: | PRINIVIL |
| Non Proprietary Name: | lisinopril |
| Active Ingredient(s): | 5 mg/1 & nbsp; lisinopril |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PRINIVIL
| Product NDC: | 0006-0019 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019558 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19871229 |
Package Information of PRINIVIL
| Package NDC: | 0006-0019-54 |
| Package Description: | 90 TABLET in 1 BOTTLE (0006-0019-54) |
NDC Information of PRINIVIL
| NDC Code | 0006-0019-54 |
| Proprietary Name | PRINIVIL |
| Package Description | 90 TABLET in 1 BOTTLE (0006-0019-54) |
| Product NDC | 0006-0019 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lisinopril |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19871229 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | LISINOPRIL |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
